Dr. Robert Liwski is the Head of the Division on Hematological Pathology, Medical Director of the HLA Laboratory and Professor of Pathology at the Queen Elizabeth II Health Sciences Centre and Dalhousie University in Halifax, Canada. He is also the Medical and Scientific Director of the HLA Laboratory at the Canadian Blood Services in Ottawa. Dr. Liwski served as Program Director of the American Society for Histocompatibility and Immunogenetics (ASHI) Proficiency Testing Committee, Chair of the Canadian HLA Laboratory Proficiency Testing Committee, Co-Chair of the Canadian National HLA Advisory Committee and is a consultant to the Brazilian Histocompatibility Association (ABH) Proficiency Testing Committee. His research interests include transplantation immunology and optimization of diagnostic testing in transplantation. Within ASHI, Dr. Liwski has been a member of the Proficiency Testing Executive Committee, the Director Training Review and Credentialing (DTRC) Committee, ASHI Quarterly Editorial Board, including Editor-in-chief, and the ASHI Board of Directors.